Fructose-1,6-bisphosphatase Inhibitors: A review of recent (2000-2017) advances and structure-activity relationship studies

Keyphrases

• Structure-activity Relationship Studies 100%
• Fructose-1,6-bisphosphatase 100%
• Type 2 Diabetes Mellitus (T2DM) 33%
• Type 1 Diabetes Mellitus (T1DM) 33%
• Diabetic 33%
• Diabetes 33%
• Recent Advances 33%
• Chronic Disease 33%
• Therapeutic Target 33%
• Increasing Prevalence 33%
• Leading Causes of Death 33%
• Diagnosed Cases 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Structure Activity Relationship 100%
• Fructose Bisphosphatase 100%
• Prevalence 33%
• Diabetes Mellitus 33%
• Chronic Disease 33%
• Non Insulin Dependent Diabetes Mellitus 33%